Intermediate-term outcome of 500 consecutive rapid-deployment surgical aortic valve procedures†

  • Martin Andreas
  • , Iuliana Coti
  • , Raphael Rosenhek
  • , Shiva Shabanian
  • , Stephane Mahr
  • , Keziban Uyanik-Uenal
  • , Dominik Wiedemann
  • , Thomas Binder
  • , Alfred Kocher
  • , Guenther Laufer

Research output: Journal article (peer-reviewed)Journal article

Abstract

The Edwards INTUITY Valve System is a balloon-expandable bioprosthesis, inspired from the Edwards Magna valve and transcatheter technology, with a subvalvular stent frame to enable rapid deployment. We report a single-centre experience of aortic valve replacement with this novel bioprosthesis. METHODS: Five hundred consecutive patients, of whom 45.6% were female with a mean age of 73.5 [standard deviation (SD) 7.9 years], with severe aortic stenosis who received a rapid deployment aortic valve between May 2010 and July 2017 were included in a prospective and ongoing database. The median follow-up time was 12 months, and the total accumulated follow-up time was 818 patient years. Preoperative characteristics, operative parameters, survival, valve-related adverse events and valve haemodynamics were assessed. Thirty-day mortality was 0.8% (4/500), and overall survival at 1, 3 and 5 years was 94%, 89% and 81%, respectively. A minimally invasive surgical approach was chosen in 236 patients (47%), of which 122 (24%) were operated on through an anterior right thoracotomy. Cross-clamp and cardiopulmonary bypass times for isolated aortic valve replacement were 53 (SD 17) and 89 (SD 29) min for full sternotomy as well as 75 (SD 23) and 110 (SD 31) min for minimally invasive surgery approaches (P < 0.001). Mean gradients at discharge, 1, 3 and 5 years were 13 (SD 5), 11 (SD 4), 12 (SD 5) and 11 (SD 3) mmHg, respectively. New pacemaker implantation was necessary in 8.6% of patients. A single case (0.2%) of structural degeneration was registered after 6 years. Valve explantation for non-structural dysfunction or endocarditis occurred in 9 patients (1.8%). CONCLUSIONS: This rapid deployment aortic valve has shown excellent results concerning haemodynamic performance, durability and safety. Implantation requires specific training, and the rate of pacemaker implantation remains a matter of concern. This novel valve also facilitates minimally invasive approaches and may be beneficial in complex combined procedures.

Original languageEnglish
Pages (from-to)527-533
Number of pages7
JournalEuropean Journal of Cardio-thoracic Surgery
Volume55
Issue number3
DOIs
Publication statusPublished - 01 Mar 2019
Externally publishedYes

Keywords

  • Aged
  • Aortic Valve/surgery
  • Aortic Valve Stenosis/surgery
  • Bioprosthesis
  • Female
  • Follow-Up Studies
  • Heart Valve Prosthesis
  • Heart Valve Prosthesis Implantation/methods
  • Humans
  • Male
  • Prospective Studies
  • Prosthesis Design
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Intermediate-term outcome of 500 consecutive rapid-deployment surgical aortic valve procedures†'. Together they form a unique fingerprint.

Cite this